ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bulk-Drug Compounding Market Research Report 2026
Published Date: 2026-02-06
|
Report Code: QYRE-Auto-35S18192
Home | Market Reports
Global Bulk Drug Compounding Market Research Report 2024
BUY CHAPTERS

Global Bulk-Drug Compounding Market Research Report 2026

Code: QYRE-Auto-35S18192
Report
2026-02-06
Pages:113
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
QuVa Pharma
Fresenius Kabi
Pharmedium
ImprimisRx
Edge Pharma
SCA Pharma
Fogron
B.Broun Melsungen AG
Nephron Pharmaceuticals Corporaiton
Central Admixture Pharmacy Services Inc
Avella Speciality Pharmacy
New England Compounding Center
Bellevue Pharmacy
Pharmazone

Bulk-Drug Compounding Market

The global Bulk-Drug Compounding market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Bulk-drug compounding refers to the process of creating medications by combining, mixing, or altering ingredients to tailor a drug specifically for an individual patient's needs. This is typically done by licensed pharmacists or physicians when commercially available medications are unsuitable for a patient. It plays a crucial role in addressing specific medical conditions that require unique formulations or dosages.
The North American market for Bulk-Drug Compounding is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Bulk-Drug Compounding is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Bulk-Drug Compounding in Prescription Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Bulk-Drug Compounding include Fogron, B.Broun Melsungen AG, Nephron Pharmaceuticals Corporaiton, Athenex Pharmaceutical Division, QuVa Pharma, Fresenius Kabi, Central Admixture Pharmacy Services Inc, PharMEDium, Avella Speciality Pharmacy, ImprimisRx, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Bulk-Drug Compounding market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Bulk-Drug Compounding. The Bulk-Drug Compounding market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Bulk-Drug Compounding market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Bulk-Drug Compounding manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Bulk-Drug Compounding Market Report

Report Metric Details
Report Name Bulk-Drug Compounding Market
Segment by Type
  • Sterile Compounding
  • Non-sterile Compounding
Segment by Application
  • Prescription Drugs
  • Over-the-Counter Drugs
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Fogron, B.Broun Melsungen AG, Nephron Pharmaceuticals Corporaiton, Athenex Pharmaceutical Division, QuVa Pharma, Fresenius Kabi, Central Admixture Pharmacy Services Inc, PharMEDium, Avella Speciality Pharmacy, ImprimisRx, Edge Pharma, SCA Pharma, New England Compounding Center, Bellevue Pharmacy, Pharmazone
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Bulk-Drug Compounding companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Bulk-Drug Compounding Market report?

Ans: The main players in the Bulk-Drug Compounding Market are Fogron, B.Broun Melsungen AG, Nephron Pharmaceuticals Corporaiton, Athenex Pharmaceutical Division, QuVa Pharma, Fresenius Kabi, Central Admixture Pharmacy Services Inc, PharMEDium, Avella Speciality Pharmacy, ImprimisRx, Edge Pharma, SCA Pharma, New England Compounding Center, Bellevue Pharmacy, Pharmazone

What are the Application segmentation covered in the Bulk-Drug Compounding Market report?

Ans: The Applications covered in the Bulk-Drug Compounding Market report are Prescription Drugs, Over-the-Counter Drugs

What are the Type segmentation covered in the Bulk-Drug Compounding Market report?

Ans: The Types covered in the Bulk-Drug Compounding Market report are Sterile Compounding, Non-sterile Compounding

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bulk-Drug Compounding Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Sterile Compounding
1.2.3 Non-sterile Compounding
1.3 Market by Application
1.3.1 Global Bulk-Drug Compounding Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Prescription Drugs
1.3.3 Over-the-Counter Drugs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bulk-Drug Compounding Market Perspective (2021–2032)
2.2 Global Bulk-Drug Compounding Growth Trends by Region
2.2.1 Global Bulk-Drug Compounding Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Bulk-Drug Compounding Historic Market Size by Region (2021–2026)
2.2.3 Bulk-Drug Compounding Forecasted Market Size by Region (2027–2032)
2.3 Bulk-Drug Compounding Market Dynamics
2.3.1 Bulk-Drug Compounding Industry Trends
2.3.2 Bulk-Drug Compounding Market Drivers
2.3.3 Bulk-Drug Compounding Market Challenges
2.3.4 Bulk-Drug Compounding Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bulk-Drug Compounding Players by Revenue
3.1.1 Global Top Bulk-Drug Compounding Players by Revenue (2021–2026)
3.1.2 Global Bulk-Drug Compounding Revenue Market Share by Players (2021–2026)
3.2 Global Top Bulk-Drug Compounding Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Bulk-Drug Compounding Revenue
3.4 Global Bulk-Drug Compounding Market Concentration Ratio
3.4.1 Global Bulk-Drug Compounding Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bulk-Drug Compounding Revenue in 2025
3.5 Global Key Players of Bulk-Drug Compounding Head Offices and Areas Served
3.6 Global Key Players of Bulk-Drug Compounding, Products and Applications
3.7 Global Key Players of Bulk-Drug Compounding, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Bulk-Drug Compounding Breakdown Data by Type
4.1 Global Bulk-Drug Compounding Historic Market Size by Type (2021–2026)
4.2 Global Bulk-Drug Compounding Forecasted Market Size by Type (2027–2032)
5 Bulk-Drug Compounding Breakdown Data by Application
5.1 Global Bulk-Drug Compounding Historic Market Size by Application (2021–2026)
5.2 Global Bulk-Drug Compounding Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Bulk-Drug Compounding Market Size (2021–2032)
6.2 North America Bulk-Drug Compounding Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Bulk-Drug Compounding Market Size by Country (2021–2026)
6.4 North America Bulk-Drug Compounding Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bulk-Drug Compounding Market Size (2021–2032)
7.2 Europe Bulk-Drug Compounding Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Bulk-Drug Compounding Market Size by Country (2021–2026)
7.4 Europe Bulk-Drug Compounding Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Bulk-Drug Compounding Market Size (2021–2032)
8.2 Asia-Pacific Bulk-Drug Compounding Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Bulk-Drug Compounding Market Size by Region (2021–2026)
8.4 Asia-Pacific Bulk-Drug Compounding Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Bulk-Drug Compounding Market Size (2021–2032)
9.2 Latin America Bulk-Drug Compounding Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Bulk-Drug Compounding Market Size by Country (2021–2026)
9.4 Latin America Bulk-Drug Compounding Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bulk-Drug Compounding Market Size (2021–2032)
10.2 Middle East & Africa Bulk-Drug Compounding Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Bulk-Drug Compounding Market Size by Country (2021–2026)
10.4 Middle East & Africa Bulk-Drug Compounding Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Fogron
11.1.1 Fogron Company Details
11.1.2 Fogron Business Overview
11.1.3 Fogron Bulk-Drug Compounding Introduction
11.1.4 Fogron Revenue in Bulk-Drug Compounding Business (2021–2026)
11.1.5 Fogron Recent Development
11.2 B.Broun Melsungen AG
11.2.1 B.Broun Melsungen AG Company Details
11.2.2 B.Broun Melsungen AG Business Overview
11.2.3 B.Broun Melsungen AG Bulk-Drug Compounding Introduction
11.2.4 B.Broun Melsungen AG Revenue in Bulk-Drug Compounding Business (2021–2026)
11.2.5 B.Broun Melsungen AG Recent Development
11.3 Nephron Pharmaceuticals Corporaiton
11.3.1 Nephron Pharmaceuticals Corporaiton Company Details
11.3.2 Nephron Pharmaceuticals Corporaiton Business Overview
11.3.3 Nephron Pharmaceuticals Corporaiton Bulk-Drug Compounding Introduction
11.3.4 Nephron Pharmaceuticals Corporaiton Revenue in Bulk-Drug Compounding Business (2021–2026)
11.3.5 Nephron Pharmaceuticals Corporaiton Recent Development
11.4 Athenex Pharmaceutical Division
11.4.1 Athenex Pharmaceutical Division Company Details
11.4.2 Athenex Pharmaceutical Division Business Overview
11.4.3 Athenex Pharmaceutical Division Bulk-Drug Compounding Introduction
11.4.4 Athenex Pharmaceutical Division Revenue in Bulk-Drug Compounding Business (2021–2026)
11.4.5 Athenex Pharmaceutical Division Recent Development
11.5 QuVa Pharma
11.5.1 QuVa Pharma Company Details
11.5.2 QuVa Pharma Business Overview
11.5.3 QuVa Pharma Bulk-Drug Compounding Introduction
11.5.4 QuVa Pharma Revenue in Bulk-Drug Compounding Business (2021–2026)
11.5.5 QuVa Pharma Recent Development
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Details
11.6.2 Fresenius Kabi Business Overview
11.6.3 Fresenius Kabi Bulk-Drug Compounding Introduction
11.6.4 Fresenius Kabi Revenue in Bulk-Drug Compounding Business (2021–2026)
11.6.5 Fresenius Kabi Recent Development
11.7 Central Admixture Pharmacy Services Inc
11.7.1 Central Admixture Pharmacy Services Inc Company Details
11.7.2 Central Admixture Pharmacy Services Inc Business Overview
11.7.3 Central Admixture Pharmacy Services Inc Bulk-Drug Compounding Introduction
11.7.4 Central Admixture Pharmacy Services Inc Revenue in Bulk-Drug Compounding Business (2021–2026)
11.7.5 Central Admixture Pharmacy Services Inc Recent Development
11.8 PharMEDium
11.8.1 PharMEDium Company Details
11.8.2 PharMEDium Business Overview
11.8.3 PharMEDium Bulk-Drug Compounding Introduction
11.8.4 PharMEDium Revenue in Bulk-Drug Compounding Business (2021–2026)
11.8.5 PharMEDium Recent Development
11.9 Avella Speciality Pharmacy
11.9.1 Avella Speciality Pharmacy Company Details
11.9.2 Avella Speciality Pharmacy Business Overview
11.9.3 Avella Speciality Pharmacy Bulk-Drug Compounding Introduction
11.9.4 Avella Speciality Pharmacy Revenue in Bulk-Drug Compounding Business (2021–2026)
11.9.5 Avella Speciality Pharmacy Recent Development
11.10 ImprimisRx
11.10.1 ImprimisRx Company Details
11.10.2 ImprimisRx Business Overview
11.10.3 ImprimisRx Bulk-Drug Compounding Introduction
11.10.4 ImprimisRx Revenue in Bulk-Drug Compounding Business (2021–2026)
11.10.5 ImprimisRx Recent Development
11.11 Edge Pharma
11.11.1 Edge Pharma Company Details
11.11.2 Edge Pharma Business Overview
11.11.3 Edge Pharma Bulk-Drug Compounding Introduction
11.11.4 Edge Pharma Revenue in Bulk-Drug Compounding Business (2021–2026)
11.11.5 Edge Pharma Recent Development
11.12 SCA Pharma
11.12.1 SCA Pharma Company Details
11.12.2 SCA Pharma Business Overview
11.12.3 SCA Pharma Bulk-Drug Compounding Introduction
11.12.4 SCA Pharma Revenue in Bulk-Drug Compounding Business (2021–2026)
11.12.5 SCA Pharma Recent Development
11.13 New England Compounding Center
11.13.1 New England Compounding Center Company Details
11.13.2 New England Compounding Center Business Overview
11.13.3 New England Compounding Center Bulk-Drug Compounding Introduction
11.13.4 New England Compounding Center Revenue in Bulk-Drug Compounding Business (2021–2026)
11.13.5 New England Compounding Center Recent Development
11.14 Bellevue Pharmacy
11.14.1 Bellevue Pharmacy Company Details
11.14.2 Bellevue Pharmacy Business Overview
11.14.3 Bellevue Pharmacy Bulk-Drug Compounding Introduction
11.14.4 Bellevue Pharmacy Revenue in Bulk-Drug Compounding Business (2021–2026)
11.14.5 Bellevue Pharmacy Recent Development
11.15 Pharmazone
11.15.1 Pharmazone Company Details
11.15.2 Pharmazone Business Overview
11.15.3 Pharmazone Bulk-Drug Compounding Introduction
11.15.4 Pharmazone Revenue in Bulk-Drug Compounding Business (2021–2026)
11.15.5 Pharmazone Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
QuVa Pharma
Fresenius Kabi
Pharmedium
ImprimisRx
Edge Pharma
SCA Pharma
Fogron
B.Broun Melsungen AG
Nephron Pharmaceuticals Corporaiton
Central Admixture Pharmacy Services Inc
Avella Speciality Pharmacy
New England Compounding Center
Bellevue Pharmacy
Pharmazone
List of Tables
 Table 1. Global Bulk-Drug Compounding Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Sterile Compounding
 Table 3. Key Players of Non-sterile Compounding
 Table 4. Global Bulk-Drug Compounding Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global Bulk-Drug Compounding Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Bulk-Drug Compounding Market Size by Region (US$ Million), 2021–2026
 Table 7. Global Bulk-Drug Compounding Market Share by Region (2021–2026)
 Table 8. Global Bulk-Drug Compounding Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global Bulk-Drug Compounding Market Share by Region (2027–2032)
 Table 10. Bulk-Drug Compounding Market Trends
 Table 11. Bulk-Drug Compounding Market Drivers
 Table 12. Bulk-Drug Compounding Market Challenges
 Table 13. Bulk-Drug Compounding Market Restraints
 Table 14. Global Bulk-Drug Compounding Revenue by Players (US$ Million), 2021–2026
 Table 15. Global Bulk-Drug Compounding Market Share by Players (2021–2026)
 Table 16. Global Top Bulk-Drug Compounding Players by Tier (Tier 1, Tier 2, and Tier 3), based on Bulk-Drug Compounding Revenue, 2025
 Table 17. Ranking of Global Top Bulk-Drug Compounding Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by Bulk-Drug Compounding Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of Bulk-Drug Compounding, Headquarters and Area Served
 Table 20. Global Key Players of Bulk-Drug Compounding, Products and Applications
 Table 21. Global Key Players of Bulk-Drug Compounding, Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global Bulk-Drug Compounding Market Size by Type (US$ Million), 2021–2026
 Table 24. Global Bulk-Drug Compounding Revenue Market Share by Type (2021–2026)
 Table 25. Global Bulk-Drug Compounding Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global Bulk-Drug Compounding Revenue Market Share by Type (2027–2032)
 Table 27. Global Bulk-Drug Compounding Market Size by Application (US$ Million), 2021–2026
 Table 28. Global Bulk-Drug Compounding Revenue Market Share by Application (2021–2026)
 Table 29. Global Bulk-Drug Compounding Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global Bulk-Drug Compounding Revenue Market Share by Application (2027–2032)
 Table 31. North America Bulk-Drug Compounding Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America Bulk-Drug Compounding Market Size by Country (US$ Million), 2021–2026
 Table 33. North America Bulk-Drug Compounding Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe Bulk-Drug Compounding Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe Bulk-Drug Compounding Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe Bulk-Drug Compounding Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific Bulk-Drug Compounding Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific Bulk-Drug Compounding Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific Bulk-Drug Compounding Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America Bulk-Drug Compounding Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America Bulk-Drug Compounding Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America Bulk-Drug Compounding Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa Bulk-Drug Compounding Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa Bulk-Drug Compounding Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa Bulk-Drug Compounding Market Size by Country (US$ Million), 2027–2032
 Table 46. Fogron Company Details
 Table 47. Fogron Business Overview
 Table 48. Fogron Bulk-Drug Compounding Product
 Table 49. Fogron Revenue in Bulk-Drug Compounding Business (US$ Million), 2021–2026
 Table 50. Fogron Recent Development
 Table 51. B.Broun Melsungen AG Company Details
 Table 52. B.Broun Melsungen AG Business Overview
 Table 53. B.Broun Melsungen AG Bulk-Drug Compounding Product
 Table 54. B.Broun Melsungen AG Revenue in Bulk-Drug Compounding Business (US$ Million), 2021–2026
 Table 55. B.Broun Melsungen AG Recent Development
 Table 56. Nephron Pharmaceuticals Corporaiton Company Details
 Table 57. Nephron Pharmaceuticals Corporaiton Business Overview
 Table 58. Nephron Pharmaceuticals Corporaiton Bulk-Drug Compounding Product
 Table 59. Nephron Pharmaceuticals Corporaiton Revenue in Bulk-Drug Compounding Business (US$ Million), 2021–2026
 Table 60. Nephron Pharmaceuticals Corporaiton Recent Development
 Table 61. Athenex Pharmaceutical Division Company Details
 Table 62. Athenex Pharmaceutical Division Business Overview
 Table 63. Athenex Pharmaceutical Division Bulk-Drug Compounding Product
 Table 64. Athenex Pharmaceutical Division Revenue in Bulk-Drug Compounding Business (US$ Million), 2021–2026
 Table 65. Athenex Pharmaceutical Division Recent Development
 Table 66. QuVa Pharma Company Details
 Table 67. QuVa Pharma Business Overview
 Table 68. QuVa Pharma Bulk-Drug Compounding Product
 Table 69. QuVa Pharma Revenue in Bulk-Drug Compounding Business (US$ Million), 2021–2026
 Table 70. QuVa Pharma Recent Development
 Table 71. Fresenius Kabi Company Details
 Table 72. Fresenius Kabi Business Overview
 Table 73. Fresenius Kabi Bulk-Drug Compounding Product
 Table 74. Fresenius Kabi Revenue in Bulk-Drug Compounding Business (US$ Million), 2021–2026
 Table 75. Fresenius Kabi Recent Development
 Table 76. Central Admixture Pharmacy Services Inc Company Details
 Table 77. Central Admixture Pharmacy Services Inc Business Overview
 Table 78. Central Admixture Pharmacy Services Inc Bulk-Drug Compounding Product
 Table 79. Central Admixture Pharmacy Services Inc Revenue in Bulk-Drug Compounding Business (US$ Million), 2021–2026
 Table 80. Central Admixture Pharmacy Services Inc Recent Development
 Table 81. PharMEDium Company Details
 Table 82. PharMEDium Business Overview
 Table 83. PharMEDium Bulk-Drug Compounding Product
 Table 84. PharMEDium Revenue in Bulk-Drug Compounding Business (US$ Million), 2021–2026
 Table 85. PharMEDium Recent Development
 Table 86. Avella Speciality Pharmacy Company Details
 Table 87. Avella Speciality Pharmacy Business Overview
 Table 88. Avella Speciality Pharmacy Bulk-Drug Compounding Product
 Table 89. Avella Speciality Pharmacy Revenue in Bulk-Drug Compounding Business (US$ Million), 2021–2026
 Table 90. Avella Speciality Pharmacy Recent Development
 Table 91. ImprimisRx Company Details
 Table 92. ImprimisRx Business Overview
 Table 93. ImprimisRx Bulk-Drug Compounding Product
 Table 94. ImprimisRx Revenue in Bulk-Drug Compounding Business (US$ Million), 2021–2026
 Table 95. ImprimisRx Recent Development
 Table 96. Edge Pharma Company Details
 Table 97. Edge Pharma Business Overview
 Table 98. Edge Pharma Bulk-Drug Compounding Product
 Table 99. Edge Pharma Revenue in Bulk-Drug Compounding Business (US$ Million), 2021–2026
 Table 100. Edge Pharma Recent Development
 Table 101. SCA Pharma Company Details
 Table 102. SCA Pharma Business Overview
 Table 103. SCA Pharma Bulk-Drug Compounding Product
 Table 104. SCA Pharma Revenue in Bulk-Drug Compounding Business (US$ Million), 2021–2026
 Table 105. SCA Pharma Recent Development
 Table 106. New England Compounding Center Company Details
 Table 107. New England Compounding Center Business Overview
 Table 108. New England Compounding Center Bulk-Drug Compounding Product
 Table 109. New England Compounding Center Revenue in Bulk-Drug Compounding Business (US$ Million), 2021–2026
 Table 110. New England Compounding Center Recent Development
 Table 111. Bellevue Pharmacy Company Details
 Table 112. Bellevue Pharmacy Business Overview
 Table 113. Bellevue Pharmacy Bulk-Drug Compounding Product
 Table 114. Bellevue Pharmacy Revenue in Bulk-Drug Compounding Business (US$ Million), 2021–2026
 Table 115. Bellevue Pharmacy Recent Development
 Table 116. Pharmazone Company Details
 Table 117. Pharmazone Business Overview
 Table 118. Pharmazone Bulk-Drug Compounding Product
 Table 119. Pharmazone Revenue in Bulk-Drug Compounding Business (US$ Million), 2021–2026
 Table 120. Pharmazone Recent Development
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources
 Table 124. Authors List of This Report


List of Figures
 Figure 1. Bulk-Drug Compounding Picture
 Figure 2. Global Bulk-Drug Compounding Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Bulk-Drug Compounding Market Share by Type: 2025 vs 2032
 Figure 4. Sterile Compounding Features
 Figure 5. Non-sterile Compounding Features
 Figure 6. Global Bulk-Drug Compounding Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global Bulk-Drug Compounding Market Share by Application: 2025 vs 2032
 Figure 8. Prescription Drugs Case Studies
 Figure 9. Over-the-Counter Drugs Case Studies
 Figure 10. Bulk-Drug Compounding Report Years Considered
 Figure 11. Global Bulk-Drug Compounding Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 12. Global Bulk-Drug Compounding Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Bulk-Drug Compounding Market Share by Region: 2025 vs 2032
 Figure 14. Global Bulk-Drug Compounding Market Share by Players in 2025
 Figure 15. Global Bulk-Drug Compounding Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 16. The Top 10 and 5 Players Market Share by Bulk-Drug Compounding Revenue in 2025
 Figure 17. North America Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
 Figure 18. North America Bulk-Drug Compounding Market Share by Country (2021–2032)
 Figure 19. United States Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. Canada Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. Europe Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Europe Bulk-Drug Compounding Market Share by Country (2021–2032)
 Figure 23. Germany Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. France Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. U.K. Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. Italy Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Russia Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Ireland Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Asia-Pacific Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Asia-Pacific Bulk-Drug Compounding Market Share by Region (2021–2032)
 Figure 31. China Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Japan Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. South Korea Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Southeast Asia Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. India Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Australia & New Zealand Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Latin America Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Latin America Bulk-Drug Compounding Market Share by Country (2021–2032)
 Figure 39. Mexico Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Brazil Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Middle East & Africa Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Middle East & Africa Bulk-Drug Compounding Market Share by Country (2021–2032)
 Figure 43. Israel Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Saudi Arabia Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. UAE Bulk-Drug Compounding Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Fogron Revenue Growth Rate in Bulk-Drug Compounding Business (2021–2026)
 Figure 47. B.Broun Melsungen AG Revenue Growth Rate in Bulk-Drug Compounding Business (2021–2026)
 Figure 48. Nephron Pharmaceuticals Corporaiton Revenue Growth Rate in Bulk-Drug Compounding Business (2021–2026)
 Figure 49. Athenex Pharmaceutical Division Revenue Growth Rate in Bulk-Drug Compounding Business (2021–2026)
 Figure 50. QuVa Pharma Revenue Growth Rate in Bulk-Drug Compounding Business (2021–2026)
 Figure 51. Fresenius Kabi Revenue Growth Rate in Bulk-Drug Compounding Business (2021–2026)
 Figure 52. Central Admixture Pharmacy Services Inc Revenue Growth Rate in Bulk-Drug Compounding Business (2021–2026)
 Figure 53. PharMEDium Revenue Growth Rate in Bulk-Drug Compounding Business (2021–2026)
 Figure 54. Avella Speciality Pharmacy Revenue Growth Rate in Bulk-Drug Compounding Business (2021–2026)
 Figure 55. ImprimisRx Revenue Growth Rate in Bulk-Drug Compounding Business (2021–2026)
 Figure 56. Edge Pharma Revenue Growth Rate in Bulk-Drug Compounding Business (2021–2026)
 Figure 57. SCA Pharma Revenue Growth Rate in Bulk-Drug Compounding Business (2021–2026)
 Figure 58. New England Compounding Center Revenue Growth Rate in Bulk-Drug Compounding Business (2021–2026)
 Figure 59. Bellevue Pharmacy Revenue Growth Rate in Bulk-Drug Compounding Business (2021–2026)
 Figure 60. Pharmazone Revenue Growth Rate in Bulk-Drug Compounding Business (2021–2026)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Drug Compounding System Market Research Report 2024
Global Automated Pharmacy Compounding Systems Market Research Report 2024
Global Packaging Plastic Compounding Market Insights Forecast to 2030
Global Automated Compounding System Market Research Report 2024
Global Hazardous Drug Compounding Systems Market Research Report 2024
Global Vet Compounding Pharmacies Market Research Report 2025
Global Rubber Compound Market Research Report 2025
Automated Drug Compounding Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
IV Compounding Robots Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Compound Customization Service Market Research Report 2025
Compounding Chemotherapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Automated Medication Compounding System Market Insights Forecast to 2030
Global Engineering Plastics Compounding Market Insights Forecast to 2030
Global Compounding Plant Solutions Market Research Report 2024
Global Compounding Pharmacy Service Market Research Report 2025
Global Compounded Topical Drug Market Research Report 2024
Global Pharmaceutical Bulk Water Market Research Report 2025
Global Compounded Pet Medications Market Research Report 2024
Global Intravenous Solution Compounder Market Research Report 2024
Global Pharmaceutical Aggregation Solution Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions